IP Library Patent Application 18537266
Patent Application
App. No. 18/537,266

CONTROLLED ROLLING CIRCLE AMPLIFICATION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/537,266
Filed
Dec 12, 2023
Examiner
KIM, YOUNG J
Art Unit
1681
USPC
435/6.11
Abstract

Disclosed herein, inter alia, are methods and compositions for improved circular polynucleotide amplification and detection.

Claims (28)

1 . A method of forming single-stranded polynucleotides in situ, the method comprising:

(a) extending a first primer hybridized to a circular polynucleotide with a strand-displacing polymerase to generate a first extension product comprising one or more complements of the circular polynucleotide within a cell or tissue;

(b) contacting the first extension product with a second immobilized primer and extending the second immobilized primer with a polymerase to generate a second immobilized extension product, wherein the second primer is immobilized to a cellular component or a matrix within the cell or tissue; and

(c) nicking the first extension product with an endonuclease, thereby generating one or more polynucleotide fragments, and removing said polynucleotide fragments, thereby forming single-stranded polynucleotides in situ.

2 . The method of claim 1 , further comprising:

(d) hybridizing a detection probe to the second immobilized extension product and detecting said detection probe, thereby detecting the circular polynucleotide.

3 . The method of claim 1 , further comprising, prior to step (c), contacting the second immobilized extension product with a third immobilized primer and extending the third immobilized primer with a polymerase to generate a third immobilized extension product, wherein the third immobilized primer is covalently immobilized to the cellular component or the matrix within the cell or tissue.

4 . The method of claim 3 , wherein step (c) further comprises nicking the second immobilized extension product with an endonuclease, thereby generating one or more additional polynucleotide fragments.

5 . The method of claim 3 , further comprising, after step (c), detecting the second immobilized extension product; followed by detecting the third immobilized extension product.

6 . The method of claim 1 , further comprising, after step (c), sequencing the second immobilized extension product.

7 . The method of claim 4 , further comprising, after step (c), sequencing the third immobilized extension product.

8 . The method of claim 6 , wherein the sequencing comprises sequencing by synthesis, sequencing by hybridization, sequencing by binding, sequencing by ligation, or pyrosequencing.

9 . The method of claim 1 , further comprising binding a specific binding reagent to a protein in the cell or tissue, wherein the specific binding reagent includes an oligonucleotide barcode, and sequencing the oligonucleotide barcode.

10 . The method of claim 1 , prior to step (a), forming the circular polynucleotide by hybridizing a first sequence of a circularizable oligonucleotide to a target nucleic acid molecule and a second sequence of the circularizable oligonucleotide to the target nucleic acid molecule, and ligating the first sequence and the second sequence to form the circular polynucleotide.

11 . The method of claim 10 , wherein the first sequence and the second sequence are adjacent.

12 . The method of claim 10 , wherein the first sequence and the second sequence are separated by 1 or more nucleotides.

13 . A method of sequencing a circular polynucleotide, the method comprising:

i) amplifying the circular polynucleotide in a cell or tissue by extending a first primer hybridized to said circular polynucleotide with a strand-displacing polymerase to generate a first extension product comprising one or more complements of the circular polynucleotide;

ii) contacting the first extension product with a second primer and extending the second primer with a polymerase to generate a second immobilized extension product, wherein the second primer is immobilized to a cellular component or a matrix within the cell or tissue;

iii) nicking the first extension product with an endonuclease, thereby generating one or more polynucleotide fragments, and removing said polynucleotide fragments, thereby forming single-stranded polynucleotides on said solid support; and

iv) hybridizing a sequencing primer to the single-stranded polynucleotides, and extending the sequencing primer to generate a first sequencing read, wherein said sequencing primer is immobilized to a cellular component or a matrix within the cell or tissue.

14 . The method of claim 13 , further comprising, prior to step (iii), contacting the second immobilized extension product with a third primer and extending the third primer with a polymerase to generate a third immobilized extension product, wherein the third primer is immobilized to a cellular component or a matrix within the cell or tissue.

15 . The method of claim 14 , wherein step (iii) comprises nicking the second immobilized extension product with an endonuclease, thereby generating one or more additional polynucleotide fragments, and removing said additional polynucleotide fragments.

16 . The method of claim 12 , wherein the endonuclease comprises one or more endonucleases selected from the group consisting of Nb.BbvCI, Nb.BsmI, NbBsrDI, Nb.BtsI, Nt.AlwI, Nt.BbvCI, Nb.BssSI, Nt.BsmAI, Nt.BspQI, Nt.BstNBI, and Nt.CviPII.

17 . The method of claim 1 , wherein the circular polynucleotide comprises any one of SEQ ID NO:1 to SEQ ID NO:20, or a complement thereof.

18 . A kit comprising a circularizable probe, a ligase, and an endonuclease, wherein said circularizable probe comprises a first hybridization sequence capable of hybridizing to a first sequence of a target polynucleotide, a second hybridization sequence capable of hybridizing to a second sequence of said target polynucleotide, and a sequence recognized by said endonuclease.

19 . The kit of claim 18 , wherein the first sequence comprises a nucleic acid sequence encoding a B cell receptor V region, and wherein the second sequence comprises a nucleic acid sequence encoding a B cell receptor J region.

20 . The kit of claim 18 , wherein the circular polynucleotide comprises any one of SEQ ID NO:1 to SEQ ID NO:20, or a complement thereof.

Assignments (2)
SECURITY INTEREST Recorded Mar 7, 2025
From: SINGULAR GENOMICS SYSTEMS, INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY
Reel/Frame 070440/0465 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2024
From: QUE, RICHARD; FABANI, MARTIN MARIA; HONG, ZHENMIN; LAWSON, MICHAEL
To: SINGULAR GENOMICS SYSTEMS, INC.
Reel/Frame 067469/0757 →